| 000 | 01832 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515182452.0 | ||
| 264 | 0 | _c20100212 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1873-7544 | ||
| 024 | 7 |
_a10.1016/j.neuroscience.2009.07.060 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamamoto, N | |
| 245 | 0 | 0 |
_aMetabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats. _h[electronic resource] |
| 260 |
_bNeuroscience _cNov 2009 |
||
| 300 |
_a1171-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDopamine Agents _xadverse effects |
| 650 | 0 | 4 |
_aDynorphins _xmetabolism |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
| 650 | 0 | 4 |
_aDystonia _xchemically induced |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aGlutamate Decarboxylase _xmetabolism |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aProtein Precursors _xmetabolism |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Metabotropic Glutamate 5 |
| 650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xantagonists & inhibitors |
| 700 | 1 | _aSoghomonian, J-J | |
| 773 | 0 |
_tNeuroscience _gvol. 163 _gno. 4 _gp. 1171-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2009.07.060 _zAvailable from publisher's website |
| 999 |
_c19067209 _d19067209 |
||